Aug 24, 2021 7:00 am EDT Castle Biosciences Awarded U.S. Federal Supply Schedule Contract for DecisionDx-Melanoma
Aug 16, 2021 7:00 am EDT Castle Biosciences Presents New Data on DecisionDx®-Melanoma and DecisionDx®-SCC at the 2021 American Academy of Dermatology (AAD) Summer Meeting
Aug 6, 2021 7:00 am EDT Castle Biosciences to Present Data at the 2021 American Academy of Dermatology (AAD) Summer Meeting
Aug 5, 2021 7:00 am EDT Castle Biosciences Presents Data on DecisionDx®-Melanoma and DecisionDx®-SCC at the DERM2021 NP/PA CME Conference
Jul 28, 2021 7:00 am EDT Castle Biosciences to Participate at the Canaccord Genuity 41st Annual Growth Conference
Jul 26, 2021 7:00 am EDT Castle Biosciences to Release Second Quarter 2021 Financial Results and Host Conference Call on Monday, Aug. 9, 2021
Jul 23, 2021 7:00 am EDT Castle Biosciences Presents New Data Demonstrating DecisionDx®-SCC Complements Current Risk Assessment Methods in Patients with Cutaneous Squamous Cell Carcinoma of the Head and Neck
Jul 22, 2021 5:00 pm EDT Castle Biosciences Presents Data on DecisionDx®-Melanoma and DecisionDx®-SCC at SDPA Annual Summer Dermatology Conference 2021
